Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

GRF analogues developed for growth hormone deficiencies

Jan. 28, 1997

Novel allergy agent claimed by French researchers

Jan. 28, 1997

Searle describes new platelet aggregation inhibitors

Jan. 28, 1997

New psychopharmacological agents developed by Ferrer

Jan. 28, 1997

Nisshin Flour Milling claims antidiabetic compounds

Jan. 28, 1997

Hair growth stimulants from Tanabe

Jan. 28, 1997

Kotobuki discloses muscarinic antagonists

Jan. 27, 1997

Sagami reports novel antitumor agents

Jan. 27, 1997

Antithrombotics described by Terumo

Jan. 27, 1997

Sumitomo claims antiplatelet agents

Jan. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.